WHO honours African American woman whose cells were used to achieve medical breakthrough researches

WHO honours African American woman whose cells were used to achieve medical breakthrough researches

The World Health Organisation (WHO) has honoured Henrietta Lacks, recognising the world-changing legacy of the black woman whose cancer cells were tak

Coronavirus: 83 Britons leave China as WHO declares it a global threat
WHO suspends trial of hydroxychloroquine as COVID-19 treatment
WHO endorses use of world’s first malaria vaccine in Africa

The World Health Organisation (WHO) has honoured Henrietta Lacks, recognising the world-changing legacy of the black woman whose cancer cells were taken out without her consent, and has provided the basis for life-changing medical breakthroughs.

In 1951, Henrietta Lacks, a Black mother of five who was dying of cervical cancer, went to Johns Hopkins Hospital in Baltimore for treatment.

Without her knowledge or consent, doctors removed a sample of cells from the tumor in her cervix. They gave the sample to a researcher at Johns Hopkins University who was trying to find cells that would survive indefinitely so researchers could experiment on them.

The invasive procedure led to a world-changing discovery: The cells became the first immortal line of human cells to divide indefinitely as it thrived and multiplied in the laboratory, something no human cells had done before.

They were reproduced billions of times, contributed to nearly 75,000 studies and helped pave the way for the HPV vaccine, medications used to help patients with H.I.V. and AIDS and, recently, the development of Covid-19 vaccines.

The HeLa cell line was developed from her tumour and the cells were mass-produced, for-profit, without recognition to her family who only found out that they had been used for science in the 1970s. Her life and legacy were documented in the book The Immortal Life of Henrietta Lacks by Rebecca Skloot, which was later made into a film.

In addition to the HPV and polio vaccines, the cells allowed for development of drugs for HIV/AIDS, haemophilia, leukaemia, and Parkinson’s disease; breakthroughs in reproductive health, including in vitro fertilisation; research on chromosomal conditions, cancer, gene mapping, and precision medicine.

Earlier this month, Lacks’s estate moved to sue a pharmaceutical company that had used the HeLa cell line. The action said the company made a “conscious choice” to mass-produce the cells and profit from a “racially unjust medical system”, the Reuters news agency reported.

The HeLa cell line was developed from her tumour and the cells were mass-produced, for-profit, without recognition to her family who only found out that they had been used for science in the 1970s.

Her life and legacy were documented in the book ‘The Immortal Life of Henrietta Lacks’ by Rebecca Skloot, which was later made into a film.

More than 50,000,000 metric tonnes of HeLa cells have been distributed around the world since they were taken from Lacks, according to the WHO.

WHO DG in recognizing her stated that Henrietta Lacks’ race and her real story were hidden by the global scientific community and described the move as “a historic wrong that today’s recognition seeks to heal”.

He said in a statement, “In honouring Henrietta Lacks, WHO acknowledges the importance of reckoning with past scientific injustices, and advancing racial equity in health and science. It’s also an opportunity to recognize women – particularly women of colour – who have made incredible but often unseen contributions to medical science.”

Henrietta Lacks’ 87-year-old son, Lawrence Lacks was present to receive the award on behalf of his mother at the WHO headquarters in Geneva, accompanied by Henrietta Lacks’ grand and great-grandchildren.

Giving his speech, Lawrence Lacks said, “We are moved to receive this historic recognition of my mother, Henrietta Lacks – honouring who she was as a remarkable woman and the lasting impact of her HeLa cells. My mother’s contributions, once hidden, are now being rightfully honored for their global impact.
“My mother was a pioneer in life, giving back to her community, helping others live a better life and caring for others. In death she continues to help the world. Her legacy lives on in us and we thank you for saying her name – Henrietta Lacks.”
Dr Princess Nothemba (Nono) Simelela, Assistant Director-General for Strategic Priorities and Special Advisor to the Director-General said, “It is unacceptable that access to the lifesaving HPV vaccine can be shaped by your race, ethnicity or where you happen to be born.
“The HPV vaccine was developed using Henrietta Lacks’ cells.  Although the cells were taken without her consent and without her knowledge, she has left behind a legacy that could potentially save millions of lives. We owe it to her and her family to achieve equitable access to this groundbreaking vaccine.”